123 related articles for article (PubMed ID: 28536967)
1. Optimization of diagnostic performance for differentiation of recurrence from radiation necrosis in patients with metastatic brain tumors using tumor volume-corrected
Jung TY; Kim IY; Lim SH; Park KS; Kim DY; Jung S; Moon KS; Jang WY; Kang SR; Cho SG; Min JJ; Bom HS; Kwon SY
EJNMMI Res; 2017 Dec; 7(1):45. PubMed ID: 28536967
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of post-treatment metabolic tumor volume from
Jung TY; Min JJ; Bom HS; Jung S; Kim IY; Lim SH; Kim DY; Kwon SY
Neurosurg Rev; 2017 Apr; 40(2):223-229. PubMed ID: 27282449
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
[TBL] [Abstract][Full Text] [Related]
4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
[TBL] [Abstract][Full Text] [Related]
5. Utility of Dynamic Susceptibility Contrast Perfusion-Weighted MR Imaging and
Qiao Z; Zhao X; Wang K; Zhang Y; Fan D; Yu T; Shen H; Chen Q; Ai L
AJNR Am J Neuroradiol; 2019 Feb; 40(2):253-259. PubMed ID: 30655259
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between Treatment-Induced Necrosis and Recurrent Tumors in Patients with Metastatic Brain Tumors: Comparison among
Tomura N; Kokubun M; Saginoya T; Mizuno Y; Kikuchi Y
AJNR Am J Neuroradiol; 2017 Aug; 38(8):1520-1527. PubMed ID: 28619837
[TBL] [Abstract][Full Text] [Related]
7. Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions.
Okamoto S; Shiga T; Hattori N; Kubo N; Takei T; Katoh N; Sawamura Y; Nishijima K; Kuge Y; Tamaki N
Ann Nucl Med; 2011 Apr; 25(3):213-20. PubMed ID: 21188660
[TBL] [Abstract][Full Text] [Related]
8. Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [
Beshr R; Isohashi K; Watabe T; Naka S; Horitsugi G; Romanov V; Kato H; Miyatake SI; Shimosegawa E; Hatazawa J
Ann Nucl Med; 2018 Dec; 32(10):702-708. PubMed ID: 30194665
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Feasibility Evaluation of 11C-Methionine Positron Emission Tomography Images in Gamma Knife Radiosurgery : Phantom-Based Study and Clinical Application.
Lim SH; Jung TY; Jung S; Kim IY; Moon KS; Kwon SY; Jang WY
J Korean Neurosurg Soc; 2019 Jul; 62(4):476-486. PubMed ID: 31154754
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of
Yomo S; Oguchi K
BMC Cancer; 2017 Nov; 17(1):713. PubMed ID: 29110648
[TBL] [Abstract][Full Text] [Related]
11. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
[TBL] [Abstract][Full Text] [Related]
13. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of
Kits A; Martin H; Sanchez-Crespo A; Delgado AF
Ann Nucl Med; 2018 Feb; 32(2):132-141. PubMed ID: 29280066
[TBL] [Abstract][Full Text] [Related]
15. Predicting tumor recurrence using metabolic indices of
Ding E; Lu D; Wei L; Feng X; Shen J; Xu W
Oncol Lett; 2020 Aug; 20(2):1245-1255. PubMed ID: 32724365
[TBL] [Abstract][Full Text] [Related]
16. Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.
Fonti R; Larobina M; Del Vecchio S; De Luca S; Fabbricini R; Catalano L; Pane F; Salvatore M; Pace L
J Nucl Med; 2012 Dec; 53(12):1829-35. PubMed ID: 23071351
[TBL] [Abstract][Full Text] [Related]
17. Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?
Incerti E; Fodor A; Mapelli P; Fiorino C; Alongi P; Kirienko M; Giovacchini G; Busnardo E; Gianolli L; Di Muzio N; Picchio M
J Nucl Med; 2015 Dec; 56(12):1836-42. PubMed ID: 26405166
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
Wu LL; Liang JH; Wang L; Xu W; Ding CY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
[No Abstract] [Full Text] [Related]
19. Comparison of F-18 FDG and C-11 methionine PET/CT for the evaluation of recurrent primary brain tumors.
Tripathi M; Sharma R; Varshney R; Jaimini A; Jain J; Souza MM; Bal J; Pandey S; Kumar N; Mishra AK; Mondal A
Clin Nucl Med; 2012 Feb; 37(2):158-63. PubMed ID: 22228339
[TBL] [Abstract][Full Text] [Related]
20. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
